Biological
Fecal sampling
Fecal sampling is a biological therapy with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Trials by Status
unknown125%
completed250%
not_yet_recruiting125%
Recent Activity
0 active trials
Showing 4 of 4
completed
Characterization of the Gut Microbiota Signature According to Physical Fitness and Its Implications for Intestinal Health.
NCT07276464
not_yet_recruiting
Association Between the Occurrence of a Clinical RElapse and Gut MIcrobiota Modifications: a Cohort Study of Patients With pSOriasis
NCT06055699
completed
Does Fidaxomicin Therapy Reduce Spread of Clostridium Difficile?
NCT02461901
unknown
The Role of Gut Microbiome and Chronic Inflammation in Young-onset Colorectal Cancer
NCT04011969
Clinical Trials (4)
Showing 4 of 4 trials
NCT07276464
Characterization of the Gut Microbiota Signature According to Physical Fitness and Its Implications for Intestinal Health.
NCT06055699
Association Between the Occurrence of a Clinical RElapse and Gut MIcrobiota Modifications: a Cohort Study of Patients With pSOriasis
NCT02461901
Does Fidaxomicin Therapy Reduce Spread of Clostridium Difficile?
NCT04011969
The Role of Gut Microbiome and Chronic Inflammation in Young-onset Colorectal Cancer
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4